Table 2.
Persistence of signs, symptoms, and diagnoses in EVD Survivors of in the Follow-up Program of Médecins Sans Frontières in Freetown, Sierra leone extracted from [16]. Data are presented as number as well as in percent within parenthesis. Abbreviations: ETC, Ebola treatment center; GERD, gastroesophageal reflux disease; STI, sexually transmitted infection.
| Signs, symptoms and diagnoses | All cases, N = 166 | Adults age ≥ 16 yrs, n = 128 | Children age ≤ 15 yrs n = 38 | Days from ETC discharge to first follow-up visit |
|||
|---|---|---|---|---|---|---|---|
| 0–30days, n = 62 | 31–60 days, n = 45 | 61–90 days, n = 21 | ≥91 days, n = 38 | ||||
| Arthralgia | 129(77.7) | 109(85.1%) | 20(52.6%) | 48(77.4%) | 34(75.5%) | 18(85.7%) | 29(76.3%) |
| Fatigue | 116(69.8) | 94(73.4%) | 22(57.8%) | 51(82.3%) | 22(48.9%) | 16(76.1%) | 27(71.0%) |
| Abdominal Pain | 90(54.2%) | 72(56.2%) | 18(47.3%) | 40(64.5%) | 21(51.1%) | 14(66.7%) | 12(34.2%) |
| Headache | 87(52.4%) | 66(51.5%) | 21(55.3%) | 36(58.0%) | 25(55.6%) | 11(52.4%) | 15(39.5%) |
| Anemia | 83(50%) | 55(42.9%) | 28(73.7%) | 36(58.0%) | 22 (48.8%) | 11(52.3%) | 14(36.8%) |
| Skin rash / infection/itching | 81(48.8%) | 54(41.2%) | 27(71.0%) | 38(61.2%) | 21(46.7%) | 9(42.8%) | 13(34.2%) |
| Back pain | 54(32.5%) | 46(35.9%) | 8(21.0%) | 25(40.3%) | 14(31.1%) | 8(38.1%) | 7(18.4%) |
| Alopecia (diffuse) | 53(31.9%) | 43(33.5%) | 10(26.3%) | 23(37.1%) | 8(17.8%) | 10(47.6%) | 12(31.6%) |
| Respiratory tract infection + otitis | 45(27.1%) | 29(22.6%) | 16(42.1%) | 17(27.4%) | 18(40.0%) | 3(14.3%) | 7(18.4%) |
| Anorexia | 43(25.9%) | 36(28.1%) | 7(18.4%) | 21(33.8%) | 11(24.4%) | 5(23.8%) | 6(15.8%) |
| Genital/urinary tract infection/STI | 38(22.8%) | 36(28.1%) | 2(5.3%) | 22(35.5%) | 5(11.1%) | 3(14.3%) | 8(21.0%) |
| Insomnia | 30(18.0%) | 29(22.6%) | 1(2.6%) | 10(16.1%) | 7(15.6%) | 4(19.0%) | 9(23.7%) |
| Gastritis/ulcer/GERD | 27(16.2%) | 26(20.3%) | 1(2.6%) | 11(17.7%) | 7(15.5%) | 4(19.0%) | 5(13.2%) |
| Malaria | 23(13.8%) | 14(10.9%) | 9(23.7%) | 10(16.1%) | 3(6.7%) | 2(9.5%) | 8(21.0%) |
| Moderate acute malnutrition | 19(11.4%) | 7(5.4%) | 12(31.6%) | 10(16.1%) | 6(13.3%) | 1(4.7%) | 2(5.2%) |
| Cardiopathy/valvulopathy/tachycardia | 19(11.4%) | 17(13.2%) | 2(5.3%) | 7(11.3%) | 6(13.3%) | 2(9.5%) | 4(10.5%) |
| Arterial hypertension | 12(7.2%) | 12(9.3%) | 0 (0%) | 4(6.4%) | 4(8.4%) | 1(4.7%) | 3(7.8%) |
| Diarrhea/gastroenteritis | 9(5.4%) | 7(5.4%) | 2(5.3%) | 5(8.0%) | 2(4.4%) | 0 (0 %) | 2(5.3%) |
| Any ocular complication | 94(56.6%) | 74(57.8%) | 20(52.6%) | 41(66.1%) | 22(48.8%) | 11(52.3%) | 20(52.6%) |
| Uveitis | 58(34.9%) | 50(39.0%) | 8(32.1%) | 26(41.9%) | 10(22.2%) | 8(38.0%) | 14(36.8%) |